European Patent Office

T 0750/18 vom 20.12.2021

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2021:T075018.20211220
Datum der Entscheidung
20. Dezember 2021
Aktenzeichen
T 0750/18
Antrag auf Überprüfung von
-
Anmeldenummer
09789380.4
IPC-Klasse
C07D 489/12
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
PROCESSES FOR THE ALKYLATION OF NORBUPRENORPHINE WITH REDUCED IMPURITY FORMATION
Name des Antragstellers
Mallinckrodt LLC
Name des Einsprechenden
isarpatent - Patent- und Rechtsanwälte Behnisch
Barth Charles Hassa Peckmann und Partner mbB
Johnson Matthey Public Limited Company
Kammer
3.3.02
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention R 139Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(2)
Schlagwörter
Correction of error - (no)
Amendments - added subject-matter (yes)
Statement of grounds of appeal - complete case (yes)
Statement of grounds of appeal - No need to raise objections against all dependent claims
Late-filed test results - admitted (no)
Inventive step - auxiliary request 5 (no)
Reply to grounds of appeal - complete case (no) - auxiliary request not substantiated
Amendment of the case after summons - exceptional circumstances (no) - auxiliary request 6 admitted (no)
Orientierungssatz
The requirement under Article 12(2) RPBA 2007 to present a complete case does not imply that an appellant/opponent, impugning a decision to maintain a patent in granted or amended form, has to raise objections against all dependent claims (point 4.2 of the reasons).
Zitierende Akten
-

Order

For these reasons it is decided that:

1. The appealed decision is set aside.

2. The patent is revoked.